Emergence of Mycobacterium leprae Rifampin Resistance Evaluated by Whole-Genome Sequencing after 48 Years of Irregular Treatment.

Mycobacterium leprae leprosy relapse emergence resistance rifampin treatment whole-genome sequencing

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
23 06 2020
Historique:
received: 03 03 2020
accepted: 13 04 2020
pubmed: 29 4 2020
medline: 22 6 2021
entrez: 29 4 2020
Statut: epublish

Résumé

A case of

Identifiants

pubmed: 32340990
pii: AAC.00330-20
doi: 10.1128/AAC.00330-20
pmc: PMC7318023
pii:
doi:

Substances chimiques

Rifampin VJT6J7R4TR

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Antimicrob Agents Chemother. 2001 Dec;45(12):3635-9
pubmed: 11709358
Nat Genet. 2011 Dec 18;44(1):106-10
pubmed: 22179134
Clin Dermatol. 2016 Jan-Feb;34(1):79-81
pubmed: 26773627
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73
pubmed: 5950347
Lepr Rev. 2004 Jun;75(2):118-30
pubmed: 15282962
J Med Microbiol. 2011 Oct;60(Pt 10):1441-1446
pubmed: 21596907
Clin Infect Dis. 2020 May 6;70(10):2054-2061
pubmed: 31260522
Clin Microbiol Infect. 2018 Dec;24(12):1305-1310
pubmed: 29496597
J Clin Microbiol. 2014 Dec;52(12):4359-60
pubmed: 25274993
Int Arch Med. 2013 Aug 30;6(1):34
pubmed: 24000954
J Vis Exp. 2011 Jul 15;(53):e3104
pubmed: 21775969
Science. 2016 Nov 11;354(6313):744-747
pubmed: 27846605

Auteurs

Charlotte Avanzi (C)

Global Health Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Raquel Cristina Maia (RC)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Andrej Benjak (A)

Global Health Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

José Augusto Nery (JA)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Anna Maria Sales (AM)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Alice Miranda (A)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Nadia Cristina Duppre (NC)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Amanda Nogueira Brum Fontes (A)

Molecular Biology Applied to Diagnosis of Mycobacterial Diseases Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Tatiana Pereira da Silva (T)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Roberta Olmo Pinheiro (R)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Fernanda Neves-Manta (F)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Suelen Justo Maria Moreira (SJM)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Philippe Busso (P)

Global Health Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Euzenir Nunes Sarno (EN)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Phillip Noel Suffys (PN)

Molecular Biology Applied to Diagnosis of Mycobacterial Diseases Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.

Stewart Thomas Cole (ST)

Global Health Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland stewart.cole@pasteur.fr milton.moraes@fiocruz.br.
Institut Pasteur, Paris, France.

Milton Ozório Moraes (MO)

Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil stewart.cole@pasteur.fr milton.moraes@fiocruz.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH